Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-Infected patients in the HAART-Era: A gicat experience

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 9, 2012, Pages 1283-1291

  Martellotta, F ^a   Berretta, M ^a   Cacopardo, B ^b   Fisichella, R ^b   Schioppa, O ^a   Zanghi A ^b   Sparta D ^b   Cappellani, A ^b   Talamini, R ^a   Izzi, I ^c   Ridolfo, A ^d   Torresin, A ^e   Fiorica, F ^f   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e GALLIERA HOSPITAL   (Italy)

^f S ANNA HOSPITAL   (Italy)

Author keywords

Anal cancer; Chemotherapy; HAART; HIV; HPV; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT;

ADULT; ANUS CARCINOMA; ANUS SQUAMOUS CELL CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CD4+ T LYMPHOCYTE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; VIRUS LOAD;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; COMBINED MODALITY THERAPY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84867944630     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. HO-YEN C, CHANG F, VAN DER WALT J, LUCAS S. Gastrointestinal malignancies in HIV-Infected or immunosuppressed patients: Pathologic features and review of the literature. Adv Anat Pathol 2007; 14: 431-443.
2. KOSHY M, KAUH J, GUNTHEL C, JOYNER M, LANDRY J, THOMAS CR. State of the art: Gastrointestinal malignancies in the human immunodeficiency virus (HIV) population. Int J Gastrointest Cancer 2005; 36: 1-14.
3. ZANET E, BERRETTA M, MARTELLOTTA F, CACOPARDO B, FISICHELLA R, TAVIO M, BERRETTA S, TIRELLI U. Anal cancer: Focus on HIV-Positive patients in the HAART era. Curr HIV Res 2011; 9: 70-81.
4. BERRETTA M, CINELLI R, MARTELLOTTA F, SPINA M, VACCHER E, TIRELLI U.Therapeutic approaches to AIDS-Related malignancies.Oncogene 2003; 22: 6646-6659.
5. OEHLER-JÄNNE C, HUGUET F, PROVENCHER S, SEIFERT B, NEGRETTI L, RIENER MO, BONET M, ALLAL AS, CIERNIK IF. HIV-Specific differences in outcome of squamous cell carcinoma of the anal canal: A multicentric cohort study of HIV-Positive patients receiving highly active antiretroviral therapy. J Clin Oncol 2008; 26: 2550-2557.
6. CHIAO EY, GIORDANO TP, RICHARDSON P, EL-SERAG HB. Human immunodeficiency virus-Associated squamous cell cancer of the anus: Epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol 2008; 26: 474-479.
7. MAGGARD MA, BEANES SR, KO CY. Anal canal cancer: A population based reappraisal. Dis Colon Rectum 2003; 46: 1517-1523.
8. FRISCH M, GLIMELIUS B, VAN DEN BRULE AJ, WOHLFAHRT J, MEIJER CJ, WALBOOMERS JM, GOLDMAN S, SVENSSON C, ADAMI HO, MELBYE M. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-1358.
9. PALEFSKY JM. Human papillomavirus infection in HIV-Infected persons. Top HIV Med 2007; 15: 130-133
10. ZBAR AP, FENGER C, EFRON J, BEER-GABEL M, WEXNER SD. The pathology and molecular biology of anal intraepithelial neoplasia: Comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis 2002; 17: 203-215.
11. BOWER M, POWLES T, NEWSOM-DAVIS T, THIRLWELL C, STEBBING J, MANDALIA S, NELSON M, GAZZARD B. HIVassociated anal cancer: Has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004; 37: 1563-1565.
12. PALEFSKY JM, HOLLY EA, RALSTON ML, DA COSTA M, BONNER H, JAY N, BERRY JM, DARRAGH TM. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 2001; 28: 422-428.
13. BERRETTA M, GARLASSI E, CACOPARDO B, CAPPELLANI A,GUARALDI G, COCCHI S, DE PAOLI P, LLESHI A,IZZI I,TORRESIN A,DI GANGI P, PIETRANGELO A, FERRARI M, BEARZ A, BERRETTA S, NASTI G, DI BENEDETTO F, BALESTRERI L, TIRELLI U, VENTURA P. Hepatocellular carcinoma in HIV Infected patients: Check early, treat hard. Oncologist 2011; 16: 1258-1269.
14. BERRETTA M, LLESHI A, CAPPELLANI A, BEARZ A, SPINA M, TALAMINI R, CACOPARDO B, NUNNARI G, MONTESARCHIO V, IZZI I, LANZAFAME M, NASTI G, BASILE F, BERRETTA S, FISICHELLA R, SCHIANTARELLI C, GARLASSI E, RIDOLFO A, GUELLA L, TIRELLI U. Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res 2010; 8: 218-222.
15. BERRETTA M, CAPPELLANI A, DI BENEDETTO F, LLESHI A, TALAMINI R, CANZONIERI V, ZANET E, BEARZ A, NASTI G, LACCHIN T, BERRETTA S, FISICHELLA R, BALESTRERI L, TORRESIN A, IZZI I, ORTOLANI P, AND TIRELLI U. Clinical presentation and outcome of colorectal cancer in HIV-Positive patients: A clinical case-Control study. Onkologie 2009; 32: 319-324.
16. DI BENEDETTO F, DI SANDRO S, DE RUVO N, BERRETTA M, MONTALTI R, GUERINI GP, BALLARIN R, DE BLASIIS MG, SPAGGIARI M, SMERIERI N, IEMMOLO RM, GUARALDI G, GERUNDA GE. Human immunodeficiency virus and liver transplantation: Our point of view: Transplant Proc 2008; 40: 1965-1971.
17. ZANET E, BERRETTA M, DI BENEDETTO F, TALAMINI R, BALLARIN R, NUNNARI G, BERRETTA S, RIDOLFO A, LLESHI A, ZANGHÌ A, CAPPELLANI A, TIRELLI U. Pancreatic Cancer in HIV-Positive Patients: A Clinical Case-Control Study. Pancreas 2012, Jun 24. [Epub ahead of print].
18. NUNNARI G, COCO C, PINZONE MR, PAVONE P, BERRETTA M, DI ROSA M, SCHNELL M, CALABRESE G, CACOPARDO B. The role of micronutrients in the diet of HIV-1-Infected individuals. Front Biosci (Elite Ed) 2012; 4: 2442-2456.
19. BEARZ A, VACCHER E, TALAMINI R, BERRETTA M, TIRELLI U. Comment on 'Lung cancer in the Swiss HIV Cohort Study: Role of smoking, immunodeficiency and pulmonary infection'. Br J Cancer 2012; 106: 1899-1900.
20. DI BENEDETTO F, BERRETTA M, DE RUVO N, TARANTINO G, D'AMICO G, BALLARIN R, IEMMOLO RM, GERUNDA GE. Is advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy? J Surg Oncol 2012; 105: 111-112.
21. TAVIO M, GROSSI P, BACCARANI U, SCUDELLER L, PEA F, BERRETTA M, ADANI G, VIVARELLI M, RIVA A, TIRELLI U, BRESADOLA V, VIALE P, RISALITI A. HIV-Infected patients and liver transplantation: Who, when and why. Curr HIV Res 2011; 9: 120-127.
22. BERRETTA M, ZANET E, BASILE F, RIDOLFO AL, DI BENEDETTO F, BEARZ A, BERRETTA S, NASTI G, TIRELLI U. HIV-Positive patients with liver metastases from colorectal cancer deserve the same therapeutic approach as the general population. Onkologie 2010; 33: 203-204.
23. DI BENEDETTO F, TARANTINO G, MONTALTI R, BALLARIN R, D'AMICO G, BERRETTA M, GERUNDA GE. Sorafenib before liver transplantation for hepatocellular carcinoma: Risk or give up. Transpl Int 2011; 24: E97.
24. DI BENEDETTO F, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, DI SANDRO S, BALLARIN R, CODELUPPI M, GUARALDI G, GERUNDA GE. Hepatocellular carcinoma in HIV patients treated by liver transplantation. Eur J Surg Oncol 2008; 34: 422-427.
25. DI BENEDETTO F, DI SANDRO S, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, BALLARIN R, COCCHI S, POTENZA L, LUPPI M, GERUNDA GE. Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol 2008; 134: 653-658.
26. BERRETTA M, DI BENEDETTO F, BEARZ A, SIMONELLI C, MARTELLOTTA F, DEL BEN C, BERRETTA S, SPINA M, TIRELLI U. FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-Infected patients: A report of five cases and review of the literature. Cancer Invest 2008; 26: 610-614.
27. DI BENEDETTO F, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, DI SANDRO S, QUINTINI C, CODELUPPI M, TIRELLI U, GERUNDA GE. Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. J Clin Oncol 2006; 24: E26-E27.
28. BERRETTA M, ZANET E, DI BENEDETTO F, SIMONELLI C, BEARZ A, MORRA A, BONANNO S, BERRETTA S, TIRELLI U. Unusual presentation of metastatic hepatocellular carcinoma in an HIV/HCV coinfected patient: Case report and review of the literature. Tumori 2008; 94: 589-591.
29. HOFFMAN R, WELTON ML, KLENCKE B, WEINBERG V, KRIEG R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-Positive patients with anal cancer. Int J Radiat Oncol Biol Phys 1999; 44: 127-131.
30. GREENE F, PAGE D, FLEMING I, FRITZ A. AJCC Cancer Staging Manual. New York: Springer-Verlag; 2002.
31. FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269: 729-730.
32. KAPLAN EL, MEIER P. Non-Parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
33. GIACALONE A, SPINA M, BERRETTA M, TIRELLI U. Two types of fatigue in cancer patients. Br J Cancer 2012; 106: 424.
34. SATO H, KOH PK, BARTOLO DC. Mangement of anal canal cancer. Dis Colon Rectum 2005; 48: 1301-1315.
35. NIGRO ND, VAITKEVICIUS VK, CONSIDINE B Jr. Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 1974; 17: 354-356.
36. BARTELINK H, ROELOFSEN F, ESCHWEGE F, ROUGIER P, BOSSET JF, GONZALEZ DG, PEIFFERT D, VAN GLABBEKE M, PIERART M. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15: 2040-2049.
37. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-Fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-Ordinating Committee on Cancer Research. Lancet 1996; 348: 1049-1054.
38. FLAM M, JOHN M, PAJAK TF, PETRELLI N, MYERSON R, DOGGETT S, QUIVEY J, ROTMAN M, KERMAN H, COIA L, MURRAY K. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 1996; 14: 2527-2539.
39. BILIMORIA KY, BENTREM DJ, ROCK CE, STEWART AK, KO CY, HALVERSON A. Outcomes and prognostic factors for squamous-Cell carcinoma of the anal canal: Analysis of patients from the National Cancer Data Base. Dis Colon Rectum 2009; 52: 624-631.
40. STADLER RF, GREGORCYK SG, EUHUS DM, PLACE RJ, HUBER PJ, SIMMANG CL. Outcome of HIV-Infected patients with invasive squamous-Cell carcinoma of the anal canal in the era of highly active antiretroviral therapy. Dis Colon Rectum 2004; 47: 1305-1309.
41. ABRAMOWITZ L, MATHIEU N, ROUDOT-THORAVAL F, LEMARCHAND N, BAUER P, HENNEQUIN C, MITRY E, ROMELAER C, APARICIO T, SOBHANI I. Epidermoid anal cancer prognosis comparison among HIV+ and HIV-Patients. Aliment Pharmacol Ther 2009; 30: 414-421.
42. FRAUNHOLZ I, WEISS C, EBERLEIN K, HABERL A, RÖDEL C. Concurrent chemoradiotherapy with 5-Fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-Positive patients receiving highly active antiretroviral therapy. Int J Radiat Oncol Biol Phys 2010; 76: 1425-1432.
43. BLAZY A, HENNEQUIN C, GORNET JM, FURCO A, GÉRARD L, LÉMANN M, MAYLIN C. Anal carcinomas in HIV-Positive patients: High-Dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 2005; 48: 1176-1181.
44. ANTONIOU T, TSENG AL. Interactions between antiretrovirals and antineoplastic drug therapy. Clin Pharmacokinet 2005; 44: 111-145.
45. HOLLAND JM, SWIFT PS. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy.Radiology 1994; 193: 251-254.
46. WEXLER A, BERSON AM, GOLDSTONE SE, WALTZMAN R, PENZER J, MAISONET OG, MCDERMOTT B, RESCIGNO J. Invasive anal squamous-Cell carcinoma in the HIV-Positive patient: Outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008; 51: 73-81.
47. CHIAO EY, GIORDANO TP, PALEFSKY JM, TYRING S, EL SERAG H. Screening HIV-Infected individuals for anal cancer precursor lesions: A systematic review. Clin Infect Dis 2006; 43: 223-233.